A new market analysis indicates significant growth in the global anemia drugs market, projecting an expansion from USD 11.22 billion in 2023 to USD 23.74 billion by 2031, exhibiting a robust CAGR of 9.91% during the forecast period of 2024-2031. This growth is primarily attributed to the rising prevalence of various types of anemia and the availability of advanced therapeutic options. Read...